Literature DB >> 17217377

Helicobacter pylori-induced apoptosis in T cells is mediated by the mitochondrial pathway independent of death receptors.

T M Ganten1, E Aravena, J Sykora, R Koschny, J Mohr, J Rudi, W Stremmel, H Walczak.   

Abstract

BACKGROUND: Chronic infection with Helicobacter pylori is related to the pathogenesis of the noncardia carcinoma of the stomach. In this study we investigated the mechanisms of H. pylori-induced apoptosis in T lymphocytes, which could explain a mechanism of immune evasion facilitating chronic inflammation of the mucosa and gastric carcinogenesis.
MATERIALS AND METHODS: The supernatant of H. pylori culture was used to study the mechanism of apoptosis induction in human leukaemia T cell lines Jurkat and CEM and in primary T cells. The cytotoxin associated gene A (CagA) and vacuolating cytotoxin A (Vac A) positive bacterial strain H. pylori 60190 (CagA(+), VacA(+)) and as a control the less toxic H. pylori strain Tx30a (CagA(-), VacA(-)) were used to produce the supernatant. Cell death was determined by DNA fragmentation and protein expression by Western blot.
RESULTS: H. pylori 60190-induced apoptosis was neither blocked by inhibition of the death ligands TRAIL (TNF-related apoptosis-inducing ligand), CD95L/FasL and TNF-alpha (tumour necrosis factor-a) in wild type Jurkat cells nor in FADD(def) (Fas-associated death domain protein) and caspase-8(def) subclones of the Jurkat cell line. Yet, the pancaspase inhibitor zVAD-fmk could inhibit up to 90% of H. pylori-induced apoptosis. Stable transfection of Jurkat wild type cells with Bcl-x(L and) Bcl-2 resulted in marked reduction of H. pylori-induced apoptosis, showing that the mitochondrial pathway is the key regulator. This is supported by the finding that surviving primary human lymphocytes upregulate Bcl-2 when exposed to H. pylori supernatant.
CONCLUSIONS: H. pylori-induced apoptosis of T cells is mediated by the mitochondrial pathway and could create a local environment that facilitates life-long infection by immune evasion.

Entities:  

Mesh:

Year:  2007        PMID: 17217377     DOI: 10.1111/j.1365-2362.2007.01761.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  6 in total

1.  Helicobacter pylori VacA reduces the cellular expression of STAT3 and pro-survival Bcl-2 family proteins, Bcl-2 and Bcl-XL, leading to apoptosis in gastric epithelial cells.

Authors:  Ayako Matsumoto; Hajime Isomoto; Masaaki Nakayama; Junzo Hisatsune; Yoshito Nishi; Yujiro Nakashima; Kayoko Matsushima; Hisao Kurazono; Kazuhiko Nakao; Toshiya Hirayama; Shigeru Kohno
Journal:  Dig Dis Sci       Date:  2010-10-07       Impact factor: 3.199

Review 2.  Immune evasion strategies used by Helicobacter pylori.

Authors:  Taslima T Lina; Shatha Alzahrani; Jazmin Gonzalez; Irina V Pinchuk; Ellen J Beswick; Victor E Reyes
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

3.  Spermine oxidase is a regulator of macrophage host response to Helicobacter pylori: enhancement of antimicrobial nitric oxide generation by depletion of spermine.

Authors:  Rupesh Chaturvedi; Mohammad Asim; Daniel P Barry; Jeanetta W Frye; Robert A Casero; Keith T Wilson
Journal:  Amino Acids       Date:  2013-07-03       Impact factor: 3.520

4.  Helicobacter pylori vacuolating toxin A and apoptosis.

Authors:  Joachim Rassow
Journal:  Cell Commun Signal       Date:  2011-11-01       Impact factor: 5.712

5.  Helicobacter pylori membrane vesicles stimulate innate pro- and anti-inflammatory responses and induce apoptosis in Jurkat T cells.

Authors:  Jody Winter; Darren Letley; Joanne Rhead; John Atherton; Karen Robinson
Journal:  Infect Immun       Date:  2014-01-13       Impact factor: 3.441

6.  Chronic in vivo exposure to Helicobacter pylori VacA: Assessing the efficacy of automated and long-term intragastric toxin infusion.

Authors:  Robin L Holland; Kristopher D Bosi; Gregory H Harpring; Jiayi Luo; Matthew Wallig; Heidi Phillips; Steven R Blanke
Journal:  Sci Rep       Date:  2020-06-09       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.